Top Vaccines companies in France by Price to Earnings Ratio (P/E)

This ranking features the top 4 Vaccines companies in France ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of 2.78, for January 15, 2025.

France

Vaccines
Price to Earnings Ratio (P/E)
#
Name
Price to Earnings Ratio (P/E)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
SAN.PA

Sanofi

1

SAN.PA

20.35

 Jan. 14, 2025 USD 96.09 -1.23%

France
2
ALNEV.PA

Neovacs S.A.

2

ALNEV.PA

-0.01

 Jan. 14, 2025 USD 0.96 -6.39%

France
3
VLA.PA

Valneva SE

3

VLA.PA

-3.22

 Jan. 14, 2025 USD 2.16 -2.19%

France
4
OSE.PA

OSE Immunotherapeutics SA

4

OSE.PA

-5.99

 Jan. 14, 2025 USD 6.91 0.46%

France
Frequently Asked Questions
  • Which Vaccines company in France has the highest Price to Earnings Ratio (P/E) ?

    The Vaccines company in France with the highest Price to Earnings Ratio (P/E) is Sanofi (Paris Stock Exchange: SAN.PA) at 20.35.

  • Which Vaccines company in France has the lowest Price to Earnings Ratio (P/E) ?

    The Vaccines company in France with the lowest Price to Earnings Ratio (P/E) is OSE Immunotherapeutics SA (Paris Stock Exchange: OSE.PA) at -5.99.